Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk, Maria Gałuszko-Węgielnik Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, PolandCorrespondence: Adam WłodarczykDepartment of Psychiatry, Faculty of Medicine, Medical University of Gdansk, 7 Dębinki Street, Bu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Szarmach J, Cubała WJ, Włodarczyk A, Gałuszko-Węgielnik M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	ketamine treatment resistant depression major depressive disorder bipolar disorder cardiovascular safety tolerability Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8d07512b47d94545a84773e3bcc5a44d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Ejemplares similares